Sa A. Wang

16.2k citations

290 papers · 5.9k · 1 hit paper · h-index 41

Impact in

Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 173
- Acute Myeloid Leukemia Research 145
- Chronic Myeloid Leukemia Treatments 51
Genetics 105
- Myeloproliferative Neoplasms: Diagnosis and Treatment 57
- Chronic Lymphocytic Leukemia Research 45

Co-authors: L. Jeffrey Medeiros (148 shared papers)Guilin Tang (90 shared papers)Jeffrey L. Jorgensen (64 shared papers)Robert P. Hasserjian (42 shared papers)Hagop M. Kantarjian (38 shared papers)Roberto N. Miranda (39 shared papers)Carlos E. Bueso‐Ramos (46 shared papers)Farhad Ravandi (41 shared papers)
Journals: American Journal of Clinical Pathology (29 papers)Modern Pathology (26 papers)Blood (23 papers)American Journal of Hematology (18 papers)Leukemia Research (18 papers)
Partner nations: United States China Germany

In The Last Decade

Sa A. Wang

276 papers receiving 5.7k citations

Sa A. Wang's Hit Papers

align trajectories log scale

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study 2012 · 323 citations

Peers

Countries citing papers authored by Sa A. Wang

Since Specialization

Citations

This map shows the geographic impact of Sa A. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sa A. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sa A. Wang more than expected).

Fields of papers citing papers by Sa A. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sa A. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sa A. Wang. The network helps show where Sa A. Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Sa A. Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sa A. Wang Line = papers co-authored together Sa A. Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 290 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study The Lancet Oncology ·Hagop M. Kantarjian, Deborah A. Thomas, Jeffrey L. Jorgensen, Elias Jabbour, Partow Kebriaei, Michael Rytting, Sergernne York, Farhad Ravandi, Monica Kwari, Stefan Faderl, Mary Beth Rios, Jörge E. Cortes, Luis Fayad, Robert Tarnai, Sa A. Wang, Richard Champlin, Anjali S. Advani, Susan O’Brien Hit paper breakdown →	2012	323
2	Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation Blood ·Stefan O. Ciurea, Peter F. Thall, Xuemei Wang, Sa A. Wang, Ying Hu, Pedro Cano, Fleur M. Aung, Gabriela Rondón, Jeffrey J. Molldrem, Martin Körbling, Elizabeth J. Shpall, Marcos de Lima, Richard E. Champlin, Marcelo Fernández-Viña	2011	158
3	Detection of MRD may predict the outcome of patients with Philadelphia chromosome–positive ALL treated with tyrosine kinase inhibitors plus chemotherapy Blood ·Farhad Ravandi, Jeffrey L. Jorgensen, Deborah A. Thomas, Susan O’Brien, Rebecca Garris, Stefan Faderl, Xuelin Huang, Sijin Wen, Jan A. Burger, Alessandra Ferrajoli, Partow Kebriaei, Richard E. Champlin, Zeev Estrov, Pramoda Challagundla, Sa A. Wang, Rajyalakshmi Luthra, Jörge E. Cortes, Hagop M. Kantarjian	2013	151
4	Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial The Lancet Haematology ·Tapan M. Kadia, Patrick K. Reville, Gautam Borthakur, Musa Yılmaz, Steven M. Kornblau, Yesid Alvarado, Courtney D. DiNardo, Naval Daver, Nitin Jain, Naveen Pemmaraju, Nicholas J. Short, Sa A. Wang, Rebecca S. Tidwell, Rabiul Islam, Marina Konopleva, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian	2021	109
5	TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases Journal of Hematology & Oncology ·Chi Young Ok, Keyur P. Patel, Guillermo Garcia‐Manero, Mark J. Routbort, Jie Peng, Guilin Tang, Maitrayee Goswami, Ken H. Young, Rajesh R. Singh, L. Jeffrey Medeiros, Hagop M. Kantarjian, Rajyalakshmi Luthra, Sa A. Wang	2015	94
6	Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases Leukemia Research ·Chi Young Ok, Keyur P. Patel, Guillermo Garcia‐Manero, Mark J. Routbort, Bin Fu, Guilin Tang, Maitrayee Goswami, Rajesh R. Singh, Rashmi Kanagal‐Shamanna, Sherry Pierce, Ken H. Young, Hagop M. Kantarjian, L. Jeffrey Medeiros, Rajyalakshmi Luthra, Sa A. Wang	2014	93
7	Lobular Intraepithelial Neoplasia [Lobular Carcinoma In Situ] With Comedo-type Necrosis The American Journal of Surgical Pathology ·Oluwole Fadare, Farnaz Dadmanesh, Isabel Alvarado‐Cabrero, Robert Snyder, Jacqueline S. Mitchell, Tibor Tot, Sa A. Wang, Mohiedean Ghofrani, Vincenzo Eusebi, Maritza Martel, Fattaneh A. Tavassoli	2006	90
8	Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified Modern Pathology ·Sa A. Wang, Wayne Tam, Albert G. Tsai, Daniel A. Arber, Robert P. Hasserjian, Julia T. Geyer, Tracy I. George, David R. Czuchlewski, Kathryn Foucar, Heesun J. Rogers, Eric D. Hsi, B Bryan Rea, Adam Bagg, Paola Dal Cin, Chong Zhao, Todd W. Kelley, Srđan Verstovšek, Carlos E. Bueso‐Ramos, Attilio Orazi	2016	88
9	Low Histologic Grade Follicular Lymphoma With High Proliferation Index The American Journal of Surgical Pathology ·Sa A. Wang, Lan Wang, Ephraim P. Hochberg, Alona Muzikansky, Nancy L. Harris, Robert P. Hasserjian	2005	87
10	Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology Archives of Pathology & Laboratory Medicine ·Daniel A. Arber, Michael J. Borowitz, Melissa H. Cessna, Joan Etzell, Kathryn Foucar, Robert P. Hasserjian, J. Douglas Rizzo, Karl S. Theil, Sa A. Wang, Anthony T. Smith, R. Bryan Rumble, Nicole Thomas, James W. Vardiman	2017	82
11	Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes Cancer ·Olga Pozdnyakova, Patricia M. Miron, Guilin Tang, Ottó Walter, Azra Raza, Bruce A. Woda, Sa A. Wang	2008	81
12	Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification Blood ·Robert P. Hasserjian, Zhuang Zuo, Christine Garcia, Guilin Tang, Armen Kasyan, Rajyalakshmi Luthra, Lynne V. Abruzzo, Hagop M. Kantarjian, L. Jeffrey Medeiros, Sa A. Wang	2009	79
13	DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease American Journal of Hematology ·Andres Quesada, Mark J. Routbort, Courtney D. DiNardo, Carlos E. Bueso‐Ramos, Rashmi Kanagal‐Shamanna, Joseph D. Khoury, Beenu Thakral, Zhuang Zuo, C. Cameron Yin, Sanam Loghavi, Chi Young Ok, Sa A. Wang, Zhenya Tang, Sarah A. Bannon, Christopher B. Benton, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Keyur P. Patel	2019	75
14	Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification Modern Pathology ·Wei Liu, Robert P. Hasserjian, Ying Hu, (unknown), Roberto N. Miranda, L. Jeffrey Medeiros, Sa A. Wang	2010	72
15	Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: Emphasis on a global evaluation and recognition of diagnostic pitfalls Leukemia Research ·Dariusz Stachurski, Brian R. Smith, Olga Pozdnyakova, Mary Andersen, Zhefu Xiao, Azra Raza, Bruce A. Woda, Sa A. Wang	2007	70
16	Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms Journal of Clinical Oncology ·Valentina Nardi, Karen M. Winkfield, Chi Young Ok, Andrzej Niemierko, Michael Kluk, Eyal C. Attar, Guillermo Garcia‐Manero, Sa A. Wang, Robert P. Hasserjian	2012	67
17	Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution American Journal of Hematology ·Guilin Tang, Liping Zhang, Bin Fu, Jianhua Hu, Xinyan Lu, Shimin Hu, Ankita Patel, Maitrayee Goswami, Joseph D. Khoury, Guillermo Garcia‐Manero, L. Jeffrey Medeiros, Sa A. Wang	2014	63
18	Systemic mastocytosis with associated clonal hematological non‐mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components American Journal of Hematology ·Sa A. Wang, Lloyd Hutchinson, Guilin Tang, Su S. Chen, Patricia M. Miron, Yang O. Huh, Dan Jones, Carlos E. Bueso‐Ramos, Srđan Verstovšek, L. Jeffrey Medeiros, Roberto N. Miranda	2012	60
19	CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia Haematologica ·Evgeniya Angelova, Charlene A. Audette, Yelena Kovtun, Naval Daver, Sa A. Wang, Sherry Pierce, Sergej Konoplev, Haitham Khogeer, Jeffrey L. Jorgensen, Marina Konopleva, Patrick A. Zweidler‐McKay, L. Jeffrey Medeiros, Hagop M. Kantarjian, Elias Jabbour, Joseph D. Khoury	2018	58
20	Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial The Lancet Haematology ·Elias Jabbour, Nicholas J. Short, Jayastu Senapati, Nitin Jain, Xuelin Huang, Naval Daver, Courtney D. DiNardo, Naveen Pemmaraju, William G. Wierda, Guillermo Garcia‐Manero, Guillermo Montalban‐Bravo, Koji Sasaki, Tapan M. Kadia, Joseph D. Khoury, Sa A. Wang, Fadi Haddad, Jovitta Jacob, Rebecca Garris, Farhad Ravandi, Hagop M. Kantarjian	2023	57

About Sa A. Wang

Sa A. Wang is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Oncology, having authored 290 papers that have together received 5.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (145 papers), Lymphoma Diagnosis and Treatment (66 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (57 papers), Chronic Myeloid Leukemia Treatments (51 papers), Chronic Lymphocytic Leukemia Research (45 papers), Acute Lymphoblastic Leukemia research (40 papers), Eosinophilic Disorders and Syndromes (33 papers) and Hematological disorders and diagnostics (17 papers). The work is most often cited by research in Hematology (3.1k citations), Genetics (1.6k citations), Pathology and Forensic Medicine (1.1k citations), Dermatology (403 citations) and Oncology (1.1k citations). Sa A. Wang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include L. Jeffrey Medeiros, Guilin Tang, Jeffrey L. Jorgensen, Robert P. Hasserjian, Hagop M. Kantarjian, Roberto N. Miranda, Carlos E. Bueso‐Ramos, Farhad Ravandi, Joseph D. Khoury and Guillermo Garcia‐Manero. Their work appears in journals such as American Journal of Clinical Pathology, Modern Pathology, Blood, American Journal of Hematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Sa A. Wang

Impact in

Papers in i

In The Last Decade

Sa A. Wang

Sa A. Wang's Hit Papers

Peers

Countries citing papers authored by Sa A. Wang

Fields of papers citing papers by Sa A. Wang

All Works

About Sa A. Wang

Explore authors with similar magnitude of impact

Papers in